KaloBios Pharmaceuticals, Inc. Reports Third Quarter 2013 Financial Results

Published: Nov 12, 2013

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (KBIO) a biopharmaceutical company with a portfolio of patient-targeted, first-in-class, monoclonal antibodies (mAbs) to treat severe respiratory diseases and cancer, announced today its corporate highlights and financial results for the third quarter ending September 30, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news